Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
7,222,335
-
Share change
-
-385,569
-
Total reported value
-
$21,748,000
-
Price per share
-
$3.02
-
Number of holders
-
13
-
Value change
-
-$1,342,201
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q2 2015
As of 30 Jun 2015,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,222,335 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, Longwood Capital Partners LLC, MILLENNIUM MANAGEMENT LLC, Lombard Odier Asset Management (USA) Corp, Cheyne Capital Management (UK) LLP, ROYAL BANK OF CANADA, and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.